DK0776199T3 - Estradiol-TTS med vandbindende additiver - Google Patents

Estradiol-TTS med vandbindende additiver

Info

Publication number
DK0776199T3
DK0776199T3 DK95929856T DK95929856T DK0776199T3 DK 0776199 T3 DK0776199 T3 DK 0776199T3 DK 95929856 T DK95929856 T DK 95929856T DK 95929856 T DK95929856 T DK 95929856T DK 0776199 T3 DK0776199 T3 DK 0776199T3
Authority
DK
Denmark
Prior art keywords
pct
water
water binding
matrix
estradiol
Prior art date
Application number
DK95929856T
Other languages
English (en)
Inventor
Ller Walter M
Michael Horstmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0776199T3 publication Critical patent/DK0776199T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95929856T 1994-08-20 1995-08-12 Estradiol-TTS med vandbindende additiver DK0776199T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4429667A DE4429667C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
PCT/EP1995/003201 WO1996005814A1 (de) 1994-08-20 1995-08-12 Estradiol-tts mit wasserbindenden zusätzen

Publications (1)

Publication Number Publication Date
DK0776199T3 true DK0776199T3 (da) 2000-04-10

Family

ID=6526231

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95929856T DK0776199T3 (da) 1994-08-20 1995-08-12 Estradiol-TTS med vandbindende additiver

Country Status (22)

Country Link
US (1) US5902602A (da)
EP (1) EP0776199B1 (da)
JP (1) JP3825799B2 (da)
KR (1) KR100401136B1 (da)
CN (1) CN1078461C (da)
AT (1) ATE185067T1 (da)
AU (1) AU695970B2 (da)
CZ (1) CZ289397B6 (da)
DE (2) DE4429667C2 (da)
DK (1) DK0776199T3 (da)
ES (1) ES2139932T3 (da)
FI (1) FI118720B (da)
GR (1) GR3032218T3 (da)
HU (1) HU226959B1 (da)
IL (1) IL114949A (da)
MX (1) MX9701302A (da)
NO (1) NO313984B1 (da)
NZ (1) NZ291813A (da)
PL (1) PL180965B1 (da)
SK (1) SK281626B6 (da)
WO (1) WO1996005814A1 (da)
ZA (1) ZA956925B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
EP4308088A4 (en) 2021-11-08 2024-06-12 Weiyong Li TRANSDERMAL DRUG DELIVERY SYSTEM FOR DELIVERING DRUG TO A PATIENT

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12731T1 (de) * 1979-01-11 1985-05-15 Key Pharma Polymere diffusionsmatrix und verfahren zu deren herstellung.
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
CA1163559A (en) * 1980-07-09 1984-03-13 Alec D. Keith Polymeric diffusion matrix for administration of drugs
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
DD279818A1 (de) * 1989-02-06 1990-06-20 Jenapharm Veb Verfahren zur herstellung eines medizinischen pflasters
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
ATE184473T1 (de) * 1992-06-11 1999-10-15 Theratech Inc Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
DE59409873D1 (de) * 1993-04-20 2001-10-25 Hexal Ag Wirkstoffpflaster

Also Published As

Publication number Publication date
NO970360D0 (no) 1997-01-28
GR3032218T3 (en) 2000-04-27
CZ289397B6 (cs) 2002-01-16
DE59506962D1 (de) 1999-11-04
CN1078461C (zh) 2002-01-30
ZA956925B (en) 1996-03-25
US5902602A (en) 1999-05-11
FI118720B (fi) 2008-02-29
FI970701A0 (fi) 1997-02-19
IL114949A (en) 1998-12-27
EP0776199A1 (de) 1997-06-04
KR970705381A (ko) 1997-10-09
JPH10504313A (ja) 1998-04-28
HUT77085A (hu) 1998-03-02
FI970701A (fi) 1997-02-19
HU226959B1 (en) 2010-03-29
AU695970B2 (en) 1998-08-27
JP3825799B2 (ja) 2006-09-27
DE4429667A1 (de) 1996-02-22
CZ50997A3 (en) 1997-06-11
PL180965B1 (pl) 2001-05-31
SK281626B6 (sk) 2001-05-10
KR100401136B1 (ko) 2004-03-31
WO1996005814A1 (de) 1996-02-29
EP0776199B1 (de) 1999-09-29
NO970360L (no) 1997-01-28
IL114949A0 (en) 1995-12-08
NO313984B1 (no) 2003-01-13
DE4429667C2 (de) 1996-07-11
AU3344995A (en) 1996-03-14
ATE185067T1 (de) 1999-10-15
MX9701302A (es) 1998-05-31
CN1155835A (zh) 1997-07-30
NZ291813A (en) 1998-01-26
PL319013A1 (en) 1997-07-21
ES2139932T3 (es) 2000-02-16
SK22097A3 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
DE59405920D1 (de) Wirkstoffhaltiges pflaster
ATE215363T1 (de) Estradiol-penetrationsverstärker zur transdermalen verabreichung
FI961282A0 (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
DK0776199T3 (da) Estradiol-TTS med vandbindende additiver
DK0680319T3 (da) Nitroglycerin-holdigt plaster, fremgangsmåde til dets fremstilling og anvendelse heraf.
DE59509643D1 (de) Transdermales therapeutisches system mit hydrolyseschutz
FI970702A (fi) Estradioli-TTS, jossa on vettä sitovia lisäaineita
ES2105334T3 (es) Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion.
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives